Daniel D. Long, SVP of Drug Discovery at Septerna Inc. ($SEPN), sold shares once on the open market in the last year, totaling about $63 thousand. His most recent sale occurred on November 10, 2025. These sales rank 10,121st among 11,678 insiders, far below the average of $8.6 million per person and 6.4 transactions. Long made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 6, 2026 | Septerna, Inc. | $SEPN | Long Daniel D. | SVP, Drug Discovery | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 45,602,099 | 9999.99% | 0.18% |
| Nov. 10, 2025 | Septerna, Inc. | $SEPN | Long Daniel D. | SVP, Drug Discovery | S | Common Stock | 3501 | $18.06 | 92,911.0000 | 45,602,099 | 3.63% | 0.01% |
| Aug. 7, 2025 | Septerna, Inc. | $SEPN | Long Daniel D. | SVP, Drug Discovery | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 9,891,126 | 9999.99% | 0.30% |